Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...

Covid hospitalizations were not significantly reduced when adults used the antiviral pill, researchers find. Also, a nationwide study suggests estrogen may play a role in long covid, putting women at ...

Why should you care? The answer is empathy. When we empathize with others, we make decisions that are greater than ourselves.

When COVID-19 vaccines rolled out, public health officials largely followed a simple logic: protect the most vulnerable first ...

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

Among adults in Ravensburg, Germany, financial incentives for COVID-19 vaccination did not result in significant changes to vaccine uptake and may have inadvertently lowered community vaccination ...